Strategic planning for U.S. premarket approval submissions

Area of Science:

• Medical device regulation
• Regulatory affairs

Background:

• The United States premarket approval (PMA) process is a regulatory pathway for medical devices.
• This process is known for being costly and time-consuming.
• It presents significant differences compared to the European Union's CE-marking process.

Purpose of the Study:

• To highlight the importance of strategic planning for PMA submissions.
• To identify key issues to consider during the PMA process.
• To provide insights for reducing the time and cost associated with PMA.

Main Methods:

• Comparative analysis of regulatory pathways.
• Discussion of strategic planning elements for PMA submissions.
• Identification of critical factors influencing PMA timelines and costs.

Main Results:

• Strategic planning is crucial for efficient PMA submissions.
• Understanding regulatory differences can optimize the process.
• Addressing specific issues proactively can mitigate delays and expenses.

Conclusions:

• Effective strategic planning can streamline the US PMA process.
• Minimizing time and cost is achievable through careful consideration of regulatory requirements and strategic approaches.
• This approach can benefit medical device manufacturers navigating regulatory hurdles.